May 30, 2014
Daiichi Sankyo Sales Chief Satoru Kimura Daiichi Sankyo will detail its antiplatelet agent Efient (prasugrel) by accentuating clinical data that show the drug is effective in reducing cardiovascular events immediately following percutaneous coronary intervention (PCI), the company’s sales head says...read more